CP 55,244
From Wikipedia, the free encyclopedia
CP 55,244
|
|
Systematic (IUPAC) name | |
(2S,4S,4aS,6R,8aR)-6-(hydroxymethyl)-4-[2-hydroxy-4-(2-methyloctan-2-yl)phenyl]-1,2,3,4,4a,5,6,7,8,8a-decahydronaphthalen-2-ol | |
Identifiers | |
CAS number | |
ATC code | ? |
PubChem | |
Chemical data | |
Formula | C26H42O3 |
Mol. mass | 402.608 g/mol |
SMILES | & |
Pharmacokinetic data | |
Bioavailability | ? |
Metabolism | ? |
Half life | ? |
Excretion | ? |
Therapeutic considerations | |
Pregnancy cat. |
? |
Legal status | |
Routes | ? |
CP 55,244 is a drug which is a cannabinoid receptor agonist. It has analgesic effects and is used in scientific research. It is a potent CB1 full agonist with a Ki of 0.21nM, making it more potent than the commonly used full agonist HU-210.[1]
[edit] References
- ^ Griffin G, Wray EJ, Martin BR, Abood ME. Cannabinoid agonists and antagonists discriminated by receptor binding in rat cerebellum. British Journal of Pharmacology. 1999 Oct;128(3):684-8. PMID 10516649
|